Bio-Rad Laboratories, Inc. (BIO) is scheduled to announce Q1 earnings results on Thursday, April 30th, after market close.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the ...

"Singular has built a competitive spatial platform and a strong foundation in a rapidly evolving market," said John Stark, CEO. "I'm excited to build on that momentum - deepening partnerships, scaling ...

We recently compiled a list of the 9 Most Undervalued Healthcare Stocks to Buy Now. Bio-Rad Laboratories, Inc. is among the ...

Rad, explores how droplet digital PCR (ddPCR) overcomes limitations of traditional PCR, reshaping how scientists approach ...

Life science company Bio-Rad Laboratories has extended its range of recombinant monoclonal anti -idiotypic antibodies. The ...

While Orange Unified is Santiago Canyon College’s primary Community Science Night partner, students and their families from ...

Bio-Rad Laboratories stock draws attention after trend movement. Explore drivers, sector position, and healthcare technology ...

First-year students enrolled in principles of biology at Commonwealth University-Lock Haven recently participated in a ...

Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2026 on Thursday, ...

Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli's next phase of growth ...

This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...